Combining volume-weighted mean nuclear volume with Gleason score and clinical stage to predict more reliably disease outcome of patients with prostate cancer

Prostate

Volumn 37, Issue 2, 1998, Pages 63-69

  Fujikawa, Keita ^a   Sasaki, Miharu ^b   Itoh, Tadahiro ^b   Arai, Yoichi ^c   Ogawa, Osamu ^d   Yoshida, Osamu ^d  

^a KOBE CITY MEDICAL CENTER GENERAL HOSPITAL   (Japan)

^b SHIZUOKA CITY SHIMIZU HOSPITAL   (Japan)

^c KURASHIKI CENTRAL HOSPITAL   (Japan)

^d KYOTO UNIVERSITY HOSPITAL   (Japan)

Author keywords

Gleason score; Mean nuclear volume; Prognostic index; Prostate cancer

Indexed keywords

FOSFESTROL; GONADORELIN DERIVATIVE;

ADULT; AGED; ARTICLE; CANCER HORMONE THERAPY; CANCER STAGING; CANCER SURVIVAL; CASTRATION; CELL NUCLEUS; CONSERVATIVE TREATMENT; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; RETROSPECTIVE STUDY;

AGED; CELL NUCLEUS; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSTATE; PROSTATIC NEOPLASMS; REPRODUCIBILITY OF RESULTS;

EID: 0031658464     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0045(19981001)37:2<63::AID-PROS1>3.0.CO;2-M     Document Type: Article

References (26)

1. Gleason DF, Mellinger GT, Veterans Administration Cooperative Urological Research Group: Prediction of prognosis for prostatic adenocarcinoma by combined histopathological grading and clinical stage. J Urol 1974;111:58-64.
2. Gleason DF: Histologic grading of prostate cancer: A perspective. Hum Pathol 1992;23:273-279.
3. Cintra ML, Billis A: Histological grading of prostatic adenocarcinoma: Intraobserver reproducibility of the Mostofi, Gleason, and Böcking grading systems. Int Urol Nephrol 1991;23:449-54.
4. Svanholm H, Mygind H: Prostatic carcinoma reproducibility of histologic grading. 1985;93:67-71.
5. Sørensen FB: Biology of disease. Quantitative analysis of nuclear size for objective malignancy grading: A review with emphasis on new, unbiased stereologic methods. Lab Invest 1992;66:4-23.
6. Gundersen HJ, Jensen EB: Stereological estimation of the volume-weighted mean volume of arbitrary particles observed on random sections. J Microsc 1985;138:127-142.
7. Gundersen HJG, Jensen EB: Particle sizes and their distributions estimated from line-and point-sampled intercepts. Including graphical unfolding. J Microsc 1983;131:291-310.
8. Fujikawa K, Sasaki M, Aoyama T, Itoh T: Prognostic criteria in patients with stage D2 prostate cancer. Correlation with mean nuclear volume. Cancer 1995;76:91-95.
9. Fujikawa K, Sasaki M, Aoyama T, Itoh T, Yoshida O: Prognostic criteria in patients with prostate cancer. Correlation with volume weighted mean nuclear volume. J Urol 1995;154:2123-2127.
10. Fujikawa K, Sasaki M, Arai Y, Yamabe H, Ogawa O, Yoshida O: Prognostic criteria in patients with prostate cancer. Gleason score versus volume weighted mean nuclear volume. Clin Cancer Res 1997;3:613-618.
11. Sasaki M, Sørensen FB, Fukuzawa S, Yamabe H, Olsen S, Yoshida O: Quantitative histopathology in the prognostic evaluation of patients with transitional cell carcinoma of the urinary bladder. Cancer 1993;72:2470-2483.
12. Nielsen K, Orntoft T, Wolf H: Stereological estimates of nuclear volume in noninvasive bladder tumors (Ta) correlated with the recurrence pattern. Cancer 1989;64:2269-2275.
13. Sørensen FB: Objective histopathological grading of cutaneous malignant melanomas by stereological estimation of nuclear volume. Prediction of survival and disease free period. Cancer 1989;63:1784-1789.
14. Sørensen FB, Kristensen IB, Grymer F, Jakobsen A: DNA level, tumor thickness and stereological estimates of nuclear volume in stage 1 cutaneous malignant melanoma. Am J Dermatopathol 1991;13:11-18.
15. Artacho-Perula E, Roldan-Villalobos R, Lopez-Rubio F, Vaamonde-Lemos R: Stereological estimates of nuclear volume in carcinoma of the ampulla of Vater. Histopathology 1992;21: 241-247.
16. Sørensen FB, Bichel P, Jakobsen A: DNA-level and stereological estimates of nuclear volume in squamous cell carcinoma of the uterine cervix: A comparative study with analysis of prognostic impact. Cancer 1992;69:187-192.
17. Fujikawa K, Sasaki M, Aoyama T, Itoh T: The role of volume-weighted mean nuclear volume for predicing disease outcome in patients with renal cell carcinoma. J Urol 1997;157:1237-1241.
18. Catalona WJ, Scott WW: Carcinoma of the prostate. In Walsh PC Gittes RF, Perlmutter AD, Stamey TA (eds): "Cambell's Urology, 5th Edition Volume 2" Philadelphia: W.B. Saunders, 1986;1463-1525.
19. Hanley JA, McNeil BJ: The meaning and use of area under a receiver operating characteristic (ROC) curve. Radiology 1982; 143:29-35.
20. Hanley JA, McNeil BJ: A method of comparing the areas under receiver operating characteristics curves derived from the same cases. Radiology 1983;148:839-846.
21. Song J, Cheng WS, Cupps RE, Earle JD, Lieber MM: Nuclear deoxyribonucleic acid content measured by static cytometry: Important prognostic association for patients with clinically localized prostate carcinoma treated by external beam radiotherapy. J Urol 1992;147:794-797.
22. Partin AW, Steinberg GD, Pitcock RV, Wu L, Piantadosi S, Cotfey D: Use of nuclear morphometry, Gleason histological scoring, clinical stage, and age to predict disease-free survival among patients with prostatic cancer. Cancer 1992;70:161-168.
23. Sørensen FB, Sasaki M, Fukuzawa S, Yamabe H, Olsen S, Yoshida O: Qualitative and quantitative histopathology in transitional cell carcinoma of the urinary bladder. Lab Invest 1994; 70:242-254.
24. Weibel ER: The value of stereology in analyzing structure and function of cells and organs. J Microsc 1972;95:3-10.
25. Stamey TA, Kabalin JN, Ferrari M, Yang N: Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. Four anti-androgen treated patients. J Urol 1989;141: 1088-1095.
26. Arai Y, Yoshiki T, Yoshida O: Prognostic significance of prostate specific antigen in endocrine treatment for prostatic cancer. J Urol 1990;144:1415-1420.